DNases, ligases, and RNA Polymerases Market Size, Share & Trends Analysis Report By DNases Application (Biopharmaceutical Processing, Other applications), By DNases Application, By RNA Polymerase Application, By Region, And By Segment Forecasts, 2025-2034
Global DNases, ligases, and RNA Polymerases Market Size is valued at USD 735.5 Mn in 2024 and is predicted to reach USD 1722.1 Mn by the year 2034 at an 9.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The rise of RNA-based therapeutics, including mRNA vaccines and RNA interference (RNAi) therapies, presents opportunities for RNA polymerases in synthesizing therapeutic RNA molecules. T...
Report ID: 1439 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
PD-1 and PD-L1 Inhibitors Market Size, Share & Trends Analysis Report By Drug Type (Atezolizumab, Avelumab, Cemiplimab, Durvalumab, Nivolumab, Pembrolizumab, Sintilimab, and Others), By Disease Type, Region And Segment Forecasts, 2025-2034
Global PD-1 and PD-L1 Inhibitors Market Size is valued at USD 48.7 Billion in 2024 and is predicted to reach USD 166.9 Billion by the year 2034 at a 13.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Rising cancer patients, sophisticated healthcare systems, and substantial healthcare expenditures propel the market. The industry has been further supported by developing combin...
Report ID: 1115 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
In Vitro Diagnostic (IVD) Reagents Market Size, Share & Trends Analysis Report By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others), By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others), By Use (Clinical Use, Research Use, Others), By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others), By Region, And By Segment Forecasts, 2025-2034
Global In Vitro Diagnostic (IVD) Reagents Market Size is valued at USD 59.3 Bn in 2024 and is predicted to reach USD 107.2 Bn by the year 2034 at a 6.2% CAGR during the forecast period for 2025-2034. In vitro diagnostic (IVD) reagents are crucial chemical compounds employed in laboratory analyses to examine samples obtained from the human body, such as blood, urine, and tissue. These substances are essential for the identification of diseases, t...
Report ID: 2452 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Eldercare-Assistive Robots Market Size, Share & Trends Analysis Report By Type (Physically Assistive Robots, Socially Assistive Robots), By Region, And By Segment Forecasts, 2025-2034
Global Eldercare-Assistive Robots Market Size is valued at USD 2.7 Bn in 2024 and is predicted to reach USD 8.5 Bn by the year 2034 at a 11.9% CAGR during the forecast period for 2025-2034. Eldercare assistive robots are specifically engineered machines created to aid senior individuals in performing daily activities and enhance their overall well-being. These robots can enhance the ability of elderly individuals to maintain their inde...
Report ID: 2469 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Pulsed Field Ablation Market Size, Share & Trends Analysis Report By Therapeutic Area (Cardiovascular Disorders, Oncological Disorders, Respiratory Disorders, Dermatological Disorders), By Product Components (Catheter, Generator, By Application Area, By Source of Ablation, By Region, And By Segment Forecasts, 2025-2034
Global Pulsed Field Ablation Market Size is valued at USD 185.6 Mn in 2024 and is predicted to reach USD 3980.4 Mn by the year 2034 at a 36.0% CAGR during the forecast period for 2025-2034. Pulsed Field Ablation (PFA) is a minimally invasive cardiac procedure for treating irregular heart rhythms like atrial fibrillation. It involves delivering high-energy electrical pulses through catheters to create precise lesions or scar tissue on the heart, ...
Report ID: 2181 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
Orphan Drugs CDMO Market Size, Share & Trends Analysis Report By Drug Type (Biologics, Non-biologics), By Therapy Type (Oncology, Neuromuscular, Respiratory, Hematology, Others), By End-User (Pharmaceutical companies, Biotechnology companies, CROs, Other End Users), By Region, And By Segment Forecasts, 2025-2034
Global Orphan Drugs CDMO Market Size is valued at USD 13.5 Bn in 2024 and is predicted to reach USD 27.6 Bn by the year 2034 at a 7.5% CAGR during the forecast period for 2025-2034. Orphan drugs, also known as orphan medicines or orphan therapies, are pharmaceuticals designed to treat rare medical illnesses known as orphan diseases. These disorders often impact a small proportion of the population, making them commercially undesirable for drug c...
Report ID: 2150 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
Clinical Trials Manufacturing and Supply Outsourcing Market Size, Share & Trends Analysis Report By Service Type (Manufacturing, Logistics & Distribution, Storage & Retention, Others), By Phase Type (Phase-I, Phase-II, Phase-III, Phase-IV), By End-User (Pharmaceutical Companies, Biotechnology Companies, Others), By Region, And By Segment Forecasts, 2025-2034
Global Clinical Trials Manufacturing and Supply Outsourcing Market Size is valued at USD 13.4 Bn in 2024 and is predicted to reach USD 22.4 Bn by the year 2034 at a 7.3% CAGR during the forecast period for 2025-2034. Clinical trial manufacturing and supply outsourcing is a strategic technique utilized by pharmaceutical and biotechnology businesses to generate the investigational medications and supplies required for clinical trials efficiently a...
Report ID: 2158 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
Transthyretin Amyloidosis Treatment Market Size and Scope 2026 to 2035
Global Transthyretin Amyloidosis Treatment Market Size is valued at USD 5.5 Bn in 2024 and is predicted to reach USD 11.7 Bn by the year 2034 at a 8.0% CAGR during the forecast period for 2025 to 2034. Transthyretin Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Type (ATTR-PN, ATTR-CM), By Therapy (Targeted Therapy (Onpattro, Inotersen, Vyndaqel/Vyndamax), Supportive Therapy, Pipeline Therapy), By Disease Type (Heredita...
Report ID: 2890 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 165
Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Application Type (Screening, Companion Diagnostics, and Other Diagnostics), By End User (Hospitals, Clinics, and Laboratories), By Technology Type (Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing & Resequencing), By Workflow Type (NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis), By Region, And By Segment Forecasts, 2025-2034
Clinical Oncology Next Generation Sequencing Market Size is valued at USD 474.2 Mn in 2024 and is predicted to reach USD 2,069.7 Mn by the year 2034 at a 16.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The global Clinical Oncology Next-Generation Sequencing market is poised for significant growth, driven by the increasing adoption of NGS technologies in cance...
Report ID: 2249 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
KRAS Inhibitors Market Size, Share & Trends Analysis Report By Cancer Type (Lung Cancer, Pancreatic Cancer, Colorectal Cancer, Others), By End-Use (Clinic Laboratories, Cancer Diagnostic Centers, Hospitals, Cancer Research Institutes, Academic Institutions, Others), By Region, And By Segment Forecasts, 2025-2034
KRAS Inhibitors Market Size is valued at USD 476.0 Mn in 2024 and is predicted to reach USD 2,916.8 Mn by the year 2034 at a 20.0% CAGR during the forecast period for 2025-2034. Kirsten rat sarcoma viral oncogene homolog inhibitor genes encode a protein in many cell signalling pathways. Several cancers, including lung, colorectal, and pancreatic cancers, often include mutations in the KRAS gene. Carcinogenesis, or the unchecked growt...
Report ID: 2251 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Pharmaceuticals